Ivan Bièche

p63/MT1-MMP axis is required for in situ to invasive transition in basal-like breast cancer

A. Vincent-Salomon, S. Vacher, I. Bièche, 2016, Oncogene.

Rucaparib in patients presenting a metastatic breast cancer with homologous recombination deficiency, without germline BRCA1/2 mutation.

I. Bièche, F. André, O. Trédan, 2020, European journal of cancer.

Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy: a proof-of-concept study

V. Servois, I. Bièche, F. Bidard, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Designs of preoperative biomarkers trials in oncology: a systematic review of the literature.

I. Bièche, X. Paoletti, A. Stathis, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestane

F. Dalenc, P. Cottu, T. Bachelot, 2024, British journal of cancer.

Modulation of Rb phosphorylation and antiproliferative response to palbociclib: the preoperative-palbociclib (POP) randomized clinical trial

I. Bièche, S. Michiels, F. André, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.